Caribou Biosciences Announces Oral Presentation on In Vivo Cas12a chRDNA Genome …

BERKELEY, Calif., April 15, 2024 (GLOBE NEWSWIRE) — Caribou Biosciences, Inc. (Nasdaq: CRBU), a leading clinical-stage CRISPR genome-editing …

Do you trust this headline?

Based on recent headline ratings, 93% of this readership currently trusts the local media, which has an average score of 79% regionally and is currently trending negative.


Media Trust Score93%